• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Defining borderline resectable pancreatic cancer: emerging consensus for an old challenge.

作者信息

Malafa Mokenge P

出版信息

J Natl Compr Canc Netw. 2015 May;13(5):501-4. doi: 10.6004/jnccn.2015.0068.

DOI:10.6004/jnccn.2015.0068
PMID:25964634
Abstract
摘要

相似文献

1
Defining borderline resectable pancreatic cancer: emerging consensus for an old challenge.定义可切除边缘的胰腺癌：对一项旧挑战达成的新共识
J Natl Compr Canc Netw. 2015 May;13(5):501-4. doi: 10.6004/jnccn.2015.0068.
2
Staging of pancreatic cancer: resectable, borderline resectable, and unresectable disease.胰腺癌分期：可切除、边界可切除和不可切除疾病。
Abdom Radiol (NY). 2018 Feb;43(2):301-313. doi: 10.1007/s00261-017-1410-2.
3
Defining venous involvement in borderline resectable pancreatic cancer.界定可切除性边缘性胰腺癌中的静脉受累情况。
Ann Surg Oncol. 2010 Nov;17(11):2832-8. doi: 10.1245/s10434-010-1284-9. Epub 2010 Aug 20.
4
Surgical treatment of resectable and borderline resectable pancreatic cancer: expert consensus statement by Evans et al.可切除及交界可切除胰腺癌的外科治疗：埃文斯等人的专家共识声明
Ann Surg Oncol. 2009 Jul;16(7):1745-50. doi: 10.1245/s10434-009-0410-z. Epub 2009 Apr 24.
5
Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement.可切除及交界可切除胰腺癌的外科治疗：专家共识声明
Ann Surg Oncol. 2009 Jul;16(7):1736-44. doi: 10.1245/s10434-009-0416-6. Epub 2009 Apr 23.
6
New developments in the management of borderline resectable pancreatic cancer.可切除边缘性胰腺癌管理的新进展
JOP. 2013 Mar 10;14(2):123-5. doi: 10.6092/1590-8577/1473.
7
Preoperative ultrasound ablation for borderline resectable pancreatic cancer: A report of 30 cases.术前超声消融治疗可切除边缘的胰腺癌：30例报告。
Ultrason Sonochem. 2015 Nov;27:694-702. doi: 10.1016/j.ultsonch.2015.05.029. Epub 2015 Jun 9.
8
Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement by Callery et al.可切除及边界可切除胰腺癌的术前评估：卡勒里等人的专家共识声明
Ann Surg Oncol. 2009 Jul;16(7):1734-5. doi: 10.1245/s10434-009-0411-y. Epub 2009 Apr 24.
9
Contemporary Management of Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer.可切除边缘性和局部进展性不可切除胰腺癌的当代管理
Oncologist. 2016 Feb;21(2):178-87. doi: 10.1634/theoncologist.2015-0316. Epub 2016 Feb 1.
10
Applicability of current NCCN Guidelines for pancreatic adenocarcinoma resectability: analysis and pitfalls.现行 NCCN 指南在胰腺腺癌可切除性评估中的适用性：分析与陷阱。
Abdom Radiol (NY). 2018 Feb;43(2):314-322. doi: 10.1007/s00261-018-1459-6.

引用本文的文献

1
KIFC1 Overexpression Promotes Pancreatic Carcinoma Progression via Stabilising BUB1B.KIFC1过表达通过稳定BUB1B促进胰腺癌进展。
J Cell Mol Med. 2025 Aug;29(16):e70767. doi: 10.1111/jcmm.70767.
2
Role of minimally invasive surgery in the management of localized pancreatic ductal adenocarcinoma: a review.微创外科在局限性胰腺导管腺癌治疗中的作用：综述。
J Robot Surg. 2024 Feb 22;18(1):85. doi: 10.1007/s11701-024-01825-w.
3
Imaging of pancreatic ductal adenocarcinoma - An update for all stages of patient management.胰腺导管腺癌的影像学检查——患者管理各阶段的最新进展
Eur J Radiol Open. 2024 Feb 8;12:100553. doi: 10.1016/j.ejro.2024.100553. eCollection 2024 Jun.
4
Surgical Feasibility, Determinants, and Overall Efficacy of Neoadjuvant Lu-DOTATATE PRRT for Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine Tumors.局部晚期不可切除胃肠胰神经内分泌肿瘤新辅助 Lu-DOTATATE PRRT 的手术可行性、决定因素和整体疗效。
J Nucl Med. 2021 Nov;62(11):1558-1563. doi: 10.2967/jnumed.120.258772. Epub 2021 Feb 26.
5
Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners.胰腺癌的新一代免疫疗法：DNA疫苗接种正在寻找新的联合伙伴。
Cancers (Basel). 2018 Feb 16;10(2):51. doi: 10.3390/cancers10020051.
6
Multimodality Management of "Borderline Resectable" Pancreatic Neuroendocrine Tumors: Report of a Single-Institution Experience.“可切除边缘”胰腺神经内分泌肿瘤的多模态管理：单机构经验报告
Cancer Control. 2017 Oct-Dec;24(5):1073274817729076. doi: 10.1177/1073274817729076.
7
Neoadjuvant Therapy of Pancreatic Cancer: Definitions and Benefits.新辅助治疗胰腺癌：定义与获益。
Int J Mol Sci. 2017 Jul 26;18(8):1622. doi: 10.3390/ijms18081622.
8
Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research.与近期转化研究相关的壶腹周围癌和胰腺癌患者的最新治疗结果
World J Gastroenterol. 2016 Dec 28;22(48):10502-10511. doi: 10.3748/wjg.v22.i48.10502.
9
Anti-α-enolase antibody limits the invasion of myeloid-derived suppressor cells and attenuates their restraining effector T cell response.抗α-烯醇化酶抗体限制髓源性抑制细胞的侵袭，并减弱其对效应T细胞反应的抑制作用。
Oncoimmunology. 2015 Dec 21;5(5):e1112940. doi: 10.1080/2162402X.2015.1112940. eCollection 2016 May.
10
CA19-9 Normalization During Pre-operative Treatment Predicts Longer Survival for Patients with Locally Progressed Pancreatic Cancer.术前治疗期间CA19-9水平正常化可预测局部进展期胰腺癌患者的生存期更长。
J Gastrointest Surg. 2016 Jul;20(7):1331-42. doi: 10.1007/s11605-016-3149-4. Epub 2016 Apr 25.